Skip to main content

Table 1 Baseline patient characteristics

From: Concurrent chemo-radiotherapy following neoadjuvant chemotherapy in locally advanced breast cancer

Variable

N= 112

Median ± SE

Number

(%)

Age (years)

50 ± 11

 

Tumor size

(cm)

5 ± 1.56

Mean, 3.93

 

Clinical T stage*

  

   T2

 

22 (19.6)

   T3

 

50 (44.6)

   T4

 

40 (35.7)

Clinical N stage*

  

   N1

 

55 (49.1)

   N2

 

56 (50)

   N3

 

1 (0.9)

Clinical stage*

  

   IIB

 

24 (21.4)

   IIIA

 

48 (42.9)

   IIIB

 

40 (35.7)

Histological grade†

  

   Low/moderate

 

45 (40.2)

   High

 

67 (59.8)

Estrogen receptors

  

   Positive

 

48 (42.9)

   Negative

 

64 (57.1)

Progesterone receptors

  

   Positive

 

46 (41.1)

   Negative

 

66 (58.9)

Treatment after CCRTh

  

   Anthracycline

 

54 (48.2)

   Taxanes

 

58 (51.8)

  1. Abbreviations: SE = standard error; CCRTh = concurrent chemo-radiotherapy.
  2. * 6th edition of the American Joint Committee on Cancer TNM classification
  3. and staging system.
  4. † Scarff-Bloom-Richardson (SBR) scale.